Bridgefront Capital, LLC Viatris Inc Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.05 - $12.02 $135,735 - $162,342	13,506 New	13,506 $143,000
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $150,532 - $182,780	-12,451 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $221,566 - $253,003	-16,722 Reduced 57.32%	12,451 $169,000
Q2 2021 Aug 12, 2021	BUY	$12.97 - $16.15 $378,373 - $471,143	29,173 New	29,173 $417,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.